Literature DB >> 21722214

Meal anticipatory rise in acylated ghrelin at dark onset is blunted after long-term fasting in rats.

P Zizzari1, R Hassouna, R Longchamps, J Epelbaum, V Tolle.   

Abstract

Ghrelin is a 28 amino acid acylated peptide originally characterised for its capacity to stimulate growth hormone secretion. Ghrelin is also an orexigenic and adipogenic hormone and is thought to be a signal to increase locomotor activity in anticipation of a scheduled meal. Although ghrelin is considered to be up-regulated during fasting, there are still conflicting data regarding the impact of starvation on ghrelin secretion. To test whether the secretory pattern of acylated ghrelin is altered during fasting, plasma levels were monitored every 20 min for 6 h in freely-behaving rats at the light/dark cycle transition, when animals initiate feeding and activity and use preferentially free fatty acids (FFA) as a source of energy. Rats were fed ad lib. or fasted at dark onset for 24, 48 or 72 h, with or without refeeding rate. The anticipatory rise in ghrelin levels, as well as home-cage activity at the onset of darkness, was significantly reduced from 48 h of fasting compared to ad lib. conditions. A delayed ghrelin peak, sensitive to renutrition, was observed in fasted animals. Although their motivation to eat appeared to be intact, rats fasted for 72 h showed the smallest compensatory refeeding rate after fasting, possibly reflecting altered gut function. Expression of agouti-related protein and neuropeptide Y, was significantly increased in 48- and 72-h fasted animals. Thus, following fasting, a blunted acylated ghrelin secretion at dark onset (i.e. a period when animals depend on FFA as a source of energy) is associated with reduced locomotor activity and refeeding and an up-regulation of anabolic neuropeptides. Such changes could be interpreted as compensatory mechanisms for helping to conserve energy under conditions where food is not available.
© 2011 The Authors. Journal of Neuroendocrinology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722214     DOI: 10.1111/j.1365-2826.2011.02183.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  6 in total

Review 1.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

Review 2.  Integration of satiety signals by the central nervous system.

Authors:  Adam P Chambers; Darleen A Sandoval; Randy J Seeley
Journal:  Curr Biol       Date:  2013-05-06       Impact factor: 10.834

3.  Metabolic Benefit of Chronic Caloric Restriction and Activation of Hypothalamic AGRP/NPY Neurons in Male Mice Is Independent of Ghrelin.

Authors:  Nicole H Rogers; Heidi Walsh; Oscar Alvarez-Garcia; Seongjoon Park; Bruce Gaylinn; Michael O Thorner; Roy G Smith
Journal:  Endocrinology       Date:  2016-01-26       Impact factor: 4.736

4.  Ghrelin receptor in agouti-related peptide neurones regulates metabolic adaptation to calorie restriction.

Authors:  Chia-Shan Wu; Odelia Y N Bongmba; Jong Han Lee; Ellie Tuchaai; Yu Zhou; De-Pei Li; Bingzhong Xue; Zheng Chen; Yuxiang Sun
Journal:  J Neuroendocrinol       Date:  2019-07-09       Impact factor: 3.627

5.  Ghrelin: central and peripheral implications in anorexia nervosa.

Authors:  Mathieu Méquinion; Fanny Langlet; Sara Zgheib; Suzanne Dickson; Bénédicte Dehouck; Christophe Chauveau; Odile Viltart
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-26       Impact factor: 5.555

6.  Circadian mechanisms of food anticipatory rhythms in rats fed once or twice daily: clock gene and endocrine correlates.

Authors:  Danica F Patton; Angela M Katsuyama; Ilya Pavlovski; Mateusz Michalik; Zachary Patterson; Maksim Parfyonov; Andrea N Smit; Elliott G Marchant; Seung Hwan Chung; John Chung; Alfonso Abizaid; Kai-Florian Storch; Horacio de la Iglesia; Ralph E Mistlberger
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.